Injectable Drug Delivery Market Type, Therapeutic, Usage Pattern, Administration, Distribution Channel, Patient Care Setting and Key Players Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.)

Injectable Drug Delivery Market analysis provides an examination of various segments that are supposed to witness the quickest development amid the estimated forecast frame. The market study of this report takes into consideration market attractiveness analysis, where each segment is benchmarked based on its market size, growth rate, and general attractiveness. This market research report helps the clients understand the various drivers and restraints impacting the market during the forecast period. Market research reports like this Injectable Drug Delivery Market surely help to reduce business risk and failure. For effectual business growth, companies must adopt market research report service which has become quite vital in this rapidly changing marketplace.

Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=232484

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care)

Prominent players in the injectable drug delivery market include

Becton, Dickinson and Company (U.S.),
Baxter International (U.S.),
Pfizer (U.S.),
Gerresheimer AG (Germany),
Schott AG (Germany),
Eli Lilly and Company (U.S.),
and Terumo Corporation (Japan).

The increase in the use of biologics, the increase in the prevalence of chronic diseases, the increasing occurrence of needle stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain) have driven the growth of the injectable drug delivery market. These factors have increased the demand for devices such as safety syringes, prefilled syringes, and auto injectors. However, the growing use of alternative delivery methods, safety concerns, and risk of transmission of blood-borne infections may hinder the growth of the market.

The injectable drug delivery is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions. Injectable drug delivery market by distribution channel is further segmented into hospitals and pharma stores. Hospitals are expected to account for a large share in this market, as hospitals provide injectables for the inpatients as well as to the outpatients, owing to which there is maximum sale of injectable formulations and devices through the hospitals. In addition, it provides pharmacy care for inpatients as well as patients from other clinics, ambulatory centers, patients discharged from healthcare facilities, and those receiving home care.

The Injectable drug delivery market by facility of use is segmented into hospitals and clinics, home care settings, and other facilities of use. The hospitals and clinics segment is expected to account for the largest share of the market, primarily due to the rising incidence of chronic diseases such as diabetes and cancer which require a large number of injectables for their treatment.

Asia is expected to be the fastest growing region in the market from 2016 to 2021due to the rising incidence of chronic and autoimmune diseases, the rising aging population, and the high penetration of self-injection techniques &technologies in countries such as China, Japan, and India.

Research Coverage:

The report defines, describes, and forecasts the injectable drug delivery market on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, and facility of use. It provides detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers &acquisitions, product developments, and expansions in the injectable drug delivery market across four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW).

Reasons to buy the report:

The report provides clients market size information on various segments of the injectable drug delivery market. This report also provides access to the quantitative data on the market. This report covers –

Current and forecast assessment of the injectable drug delivery market
Country-wise assessment of each of the segments
Global market share analysis for major segments of the injectable drug delivery market
Adoption Trends of injectable drug delivery for major geographic markets
Five-year coverage of strategic developments of top players in the injectable drug delivery market
Product Portfolio mapping of leading players in the injectable drug delivery market

Get Discount on the Latest Report @ https://www.reportsnreports.com/contacts/discount.aspx?name=232484

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Market Overview
4.2 Injectable Drug Delivery Market, By Facility of Use
4.3 Geographic Analysis: By Site of Administration
4.4 Injectable Drug Delivery Market, By Formulation Packaging
4.5 Geographical Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Chronic Diseases
5.2.1.2 Increase in Demand for Self-Injection Devices
5.2.1.3 Growth in the Biologics Market
5.2.1.4 Technological Advancements and New Product Launches
5.2.2 Restraints
5.2.2.1 Infections Associated With Needlestick Injuries
5.2.2.2 Product Recalls
5.2.3 Opportunities
5.2.3.1 Increase in Demand for Biosimilar and Generic Injectables
5.2.3.1.1 Biosimilars
5.2.3.1.2 Generic Injectables
5.2.3.2 Contraceptive Injectables
5.2.4 Challenge
5.2.4.1 Preference for Other Modes of Drug Delivery

6 Regulatory Scenario
6.1 Introduction
6.2 FDA and CE Approvals
6.3 The European Medicines Agency (EMA)
6.4 Clinical Trials

7 Injectable Drug Delivery Market, By Type
7.1 Introduction
7.2 Devices
7.2.1 Conventional Injection Devices
7.2.1.1 By Material
7.2.1.1.1 Glass
7.2.1.1.2 Plastic
7.2.1.2 By Product
7.2.1.2.1 Fillable Syringes
7.2.1.2.2 Prefilled Syringes
7.2.1.3 By Usability
7.2.1.3.1 Reusable Injection Devices
7.2.1.3.2 Disposable Injection Devices
7.2.2 Self-Injection Devices
7.2.2.1 Needle-Free Injectors
7.2.2.1.1 By Product
7.2.2.1.1.1 Fillable Needle-Free Injectors
7.2.2.1.1.2 Prefilled Needle-Free Injectors
7.2.2.1.2 By Technology
7.2.2.1.2.1 Jet-Based Needle-Free Injectors
7.2.2.1.2.2 Spring-Based Needle-Free Injectors
7.2.2.1.2.3 Laser-Powered Needle-Free Injectors
7.2.2.1.2.4 Vibration-Based Needle-Free Injectors
7.2.2.1.3 By Usability
7.2.2.1.3.1 Reusable Needle-Free Injectors
7.2.2.1.3.2 Disposable Needle-Free Injectors
7.2.2.2 Autoinjectors
7.2.2.2.1 By Product
7.2.2.2.1.1 Fillable Autoinjectors
7.2.2.2.1.2 Prefilled Autoinjectors
7.2.2.2.2 By Technology
7.2.2.2.2.1 Automated Autoinjectors
7.2.2.2.2.2 Manual Autoinjectors
7.2.2.2.3 By Design
7.2.2.2.3.1 Standardized Autoinjectors
7.2.2.2.3.2 Customized Autoinjectors
7.2.2.2.4 By Usability
7.2.2.2.4.1 Reusable Autoinjectors
7.2.2.2.4.2 Disposable Autoinjectors
7.2.2.3 Pen Injectors
7.2.2.3.1 By Product
7.2.2.3.1.1 Single-Chambered Pen Injectors
7.2.2.3.1.2 Dual-Chambered Pen Injectors
7.2.2.3.2 By Design
7.2.2.3.2.1 Standard Pen Injectors
7.2.2.3.2.2 Customized Pen Injectors
7.2.2.3.3 By Usability
7.2.2.3.3.1 Reusable Pen Injectors
7.2.2.3.3.2 Disposable Pen Injectors
7.2.2.4 Wearable Injectors
7.2.2.5 Other Devices
7.3 Formulations
7.3.1 Conventional Drug Delivery Formulations
7.3.1.1 Solutions
7.3.1.2 Reconstituted/Lyophilized Formulations
7.3.1.3 Suspensions
7.3.1.4 Emulsions
7.3.2 Novel Drug Delivery Formulations
7.3.2.1 Colloidal Dispersions
7.3.2.1.1 Niosomes
7.3.2.1.2 Liposomes
7.3.2.1.3 Polymeric/Mixed Micelles
7.3.2.1.4 Nanoparticles
7.3.2.1.4.1 Solid-Lipid Nanoparticles
7.3.2.1.4.2 Nanosuspensions
7.3.2.1.4.3 Nanoemulsions
7.3.2.2 Microparticles
7.3.2.2.1 Microspheres
7.3.2.2.2 Microcapsules
7.3.3 Long-Acting Injection Formulations

8 Injectable Drug Delivery Market, By Formulation Packaging
8.1 Introduction
8.2 Ampules
8.3 Vials
8.4 Cartridges
8.5 Bottles

9 Injectable Drug Delivery Market, By Therapeutic Application
9.1 Introduction
9.2 Autoimmune Diseases
9.2.1 Rheumatoid Arthritis
9.2.2 Multiple Sclerosis (MS)
9.2.3 Crohn’s Disease
9.2.4 Psoriasis
9.2.5 Other Autoimmune Diseases
9.3 Hormonal Disorders
9.3.1 Diabetes
9.3.2 Anemia
9.3.3 Reproductive Health Disease
9.3.4 Antithrombotic/Thrombolytic Therapy
9.3.5 Osteoporosis
9.3.6 Growth Hormone Deficiency (GHD)
9.4 Orphan Diseases
9.5 Cancer
9.6 Other Therapeutic Applications
9.6.1 Pain Management
9.6.2 Allergies
9.6.3 Aesthetic Treatment
9.6.4 Hepatitis C
9.6.5 Hemophilia

10 Injectable Drug Delivery Market, By Usage Pattern
10.1 Introduction
10.2 Curative Care
10.3 Immunization
10.4 Others

11 Injectable Drug Delivery Market, By Site of Administration
11.1 Introduction
11.2 Skin (Intradermal and Subcutaneous)
11.3 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
11.4 Organs (Intravitreal and Intra-Articular)
11.5 Central Nervous System (Intracerebral and Intrathecal)

12 Injectable Drug Delivery Market, By Distribution Channel
12.1 Introduction
12.2 Hospitals
12.3 Retail Pharmacy Stores

13 Injectable Drug Delivery Market, By Facility of Use
13.1 Introduction
13.2 Hospitals and Clinics
13.3 Home Care Settings
13.4 Other Facilities of Use

14 Injectable Drug Delivery Market, By Region
14.1 Introduction
14.2 North America
14.2.1 U.S.
14.2.2 Canada
14.3 Europe
14.3.1 Germany
14.3.2 France
14.3.3 U.K.
14.3.4 Italy
14.3.5 Spain
14.3.6 Rest of Europe (RoE)
14.4 Asia
14.4.1 China
14.4.2 Japan
14.4.3 India
14.4.4 Rest of Asia
14.5 Rest of the World (RoW)

15 Competitive Landscape
15.1 Overview
15.2 Market Share Analysis
15.3 Competitive Situation and Trends
15.3.1 Partnerships, Agreements, and Collaborations
15.3.2 Product Launches, Approvals, and Enhancements
15.3.3 Expansions
15.3.4 Acquisitions

16 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
16.1 Introduction
16.2 Baxter International, Inc.
16.3 Becton, Dickinson and Company
16.4 Gerresheimer AG
16.5 Pfizer, Inc.
16.6 Schott AG
16.7 ELI Lilly and Company
16.8 Sandoz (A Division of Novartis AG)
16.9 Terumo Corporation
16.10 Teva Pharmaceutical Industries Ltd.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

17 Appendix
17.1 Insights From Industry Experts
17.2 Discussion Guide
17.3 Other Recent Developments
17.4 Available Customizations
17.5 Knowledge Store: Marketsandmarkets’ Subscription Portal
17.6 RT: Real-Time Market Intelligence
17.7 Related Reports
17.8 Author Details

Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=232484

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.